Again, I think those are excellent concerns. If you look again in terms of what's happening internationally, I think it provides a lot of good commentary. As Maureen says, most of these are rare disorders, so you do have international expertise. You can't just rely on what's available in Canada. You do have to be connected internationally. The patients are connected internationally, and many of our clinicians, if they belong to international associations, are connected internationally. But our regulatory bodies and our approval bodies have also got to be connected internationally. It goes back to what Dr. Bennett is saying. We know we already have frameworks for approval in other countries. We've been talking about harmonization in terms of regulatory framework, so I wouldn't necessarily say we want to relax the regulatory framework--I understand what you mean--but I think what we want to do is to modernize it, and we want to be able to harmonize it so that we can take advantage of what is happening in other countries.
On June 3rd, 2010. See this statement in context.